P-113d, an Antimicrobial Peptide Active against Pseudomonas aeruginosa, Retains Activity in the Presence of Sputum from Cystic Fibrosis Patients

Antimicrobial peptides are a source of novel agents that could be useful for treatment of the chronic lung infections that afflict cystic fibrosis (CF) patients. Efficacy depends on antimicrobial activity against the major pathogens of CF patients, Pseudomonas aeruginosa, Staphylococcus aureus, and...

Descripció completa

Dades bibliogràfiques

Publicat a:	Antimicrob Agents Chemother
Autors principals:	Sajjan, Umadevi S., Tran, Linh T., Sole, Nuria, Rovaldi, Christopher, Akiyama, Alan, Friden, Phillip M., Forstner, Janet F., Rothstein, David M.
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 2001
Matèries:	Susceptibility
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90850/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11709321/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.12.3437-3444.2001
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!